Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Receivables: 2018-2025

Historic Change in Receivables for AC Immune (ACIU) over the last 3 years, with Sep 2025 value amounting to -$526,281.

  • AC Immune's Change in Receivables fell 248.04% to -$526,281 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 195.55%. This contributed to the annual value of $16.9 million for FY2024, which is 201.26% up from last year.
  • Per AC Immune's latest filing, its Change in Receivables stood at -$526,281 for Q3 2025, which was down 208.38% from $485,572 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Change in Receivables registered a high of $17.1 million during Q4 2024, and its lowest value of -$16.7 million during Q4 2023.
  • In the last 3 years, AC Immune's Change in Receivables had a median value of -$222,719 in 2023 and averaged -$69,288.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 557.96% in 2023, then plummeted by 248.04% in 2025.
  • Quarterly analysis of 5 years shows AC Immune's Change in Receivables stood at $107,471 in 2021, then tumbled by 166.66% to -$71,642 in 2022, then spiked by 557.96% to -$16.7 million in 2023, then skyrocketed by 202.74% to $17.1 million in 2024, then crashed by 248.04% to -$526,281 in 2025.
  • Its last three reported values are -$526,281 in Q3 2025, $485,572 for Q2 2025, and -$947,637 during Q1 2025.